Please login to the form below

Not currently logged in


This page shows the latest RLF-100 news and features for those working in and with pharma, biotech and healthcare.

Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout

Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout

Relief and NeuroRx are still awaiting the detailed results from rigorous randomised studies of RLF-100 (aviptadil) for the treatment of COVID-19 patients. ... The companies said that 81% of patients treated with RLF-100 survived beyond 60 days, compared

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...